OSCR
Oscar Health Inc
$33.18-5.71%
Setup
Watch
Buy Zone
$32.28-$33.89
Sector
Healthcare Plans
Industry
Healthcare Plans
88
Recommendation
No setup
Hold
No active chart path confirmed. Keep on watchlist until price, volume, and setup align.
OSCR chart
Loading chart…
Overall Quality88
RS Rating
95
relative strength
Fundamentals
82
Strong fund-Q
Volume Demand
68
+112% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Healthcare Plans
Trade Plan
No setup
Entry
$32.28
Entry Zone
$32.28-$33.89
Stop / Risk
$29.7
RS Rating
95
Volume confirmed
No
Targets
$38.74 / $40.35
Breakout · IBD Setup
5 ✓ 3 ✗
Entry $32.28–$33.89Stop $29.7Target $38.74 / $40.35
Market regimeRange
Quality88
RS Rating95
Above 50-MA+4.24%
Above 200-MA+38.63%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
88
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q82 · Strong
StatusHold
Stock Data
52-Week Range11 – 36
Price % Chg YTD130.9%
Price % Chg 4wk0.82%
50-Day Avg Vol5.5 Mil
P/E Ratio22.2
Market Cap$9B
SectorHealthcare
IndustryHealthcare Plans
Company Fundamentals
EPS % Chg (Qtr)221.42%
Sales % Chg (Qtr)70.4%
EPS Growth 5y0.13%
Sales Growth 5y90.8%
Annual ROE34.31%
Gross Margin—
Operating Margin4.11%
Net Margin3.6%
Debt / Equity0.21
Setup levels
Current price
$33.18
Pivot
$32.28
Distance to buy
-8.2%
52-week range
10.69-36.16
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 34.31%
Net margin above 10%
Net margin 3.6%
EPS growing quarter on quarter
EPS q/q 221.42%
Sales growing quarter on quarter
Sales q/q 70.4%
Debt to equity below 1.0
D/E 0.21
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE34.31%
vs sector +11.7%
Net margin3.6%
vs sector -14.1%
Gross margin—
EPS growth q/q221.42%
vs sector +213.8%
Sales growth q/q70.4%
vs sector +51.7%
Debt / equity0.21
vs sector -0.44
Business quality
82
GradeStrong
EPS rating87
P/E22.2
Market cap$9B
IndustryHealthcare Plans
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-02
Trigger date
—
Days on list
4
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.